Spotlight on Science Meetings, Conferences and Events brings you information on the following event:Terminally ill Patients and the ‘Right to Try’: Practical, Legal, and Ethical Issues in Expanded Access to Investigational Drugs
The webinar will review the legal framework of FDA’s expanded access regulations and the recent initiative to pass ‘Right to Try’ laws at the state level, which are designed to allow patients access to investigational treatments without the need for FDA approval.
The webinar will provide the historical context of challenges to FDA’s authority to regulate access to investigational drugs by seriously ill patients who do not qualify for an ongoing clinical and for whom there is no approved therapy, and the ensuing development of the ‘Right to Try’ initiative.
An update on the number of states that have passed ‘Right to Try’ laws will be provided and the similarities and differences between the various state laws will be reviewed.
The webinar will explore legal tension between the FDA regulations and the state ‘Right to Try’ laws, and the latest efforts to pass a National ‘Right to Try’ Law.
Thursday, July 13, 2017